Medix Inc. (331A)

Price history

¥475Latest-30.5%

Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis

Business overview

A corporate group operating a single segment, digital marketing support services. The group comprises 6 companies, namely the parent company and 5 consolidated subsidiaries: Sales Lab, 亞星通股份有限公司, Start Asia Japan, 日台通販國際股份有限公司, and 美迪科思行銷股份有限公司. Its core business is performance-based advertising, providing end-to-end digital marketing services through a single point of contact. Services include overseas market support, data management, website development, and sales support. The group holds numerous certifications as a major partner. Its sales policy is divided into 3 areas: BtoC, BtoB, and data management and other services. Its growth strategy centers on Beyond Advertising, with the launch of new products, expansion of data management services, and overseas expansion. Since 1998, it has provided marketing support to IT companies. Financial indicators for the 43rd and 42nd fiscal years have been disclosed.

Recurring subjects

No threads yetThis company's filings have not been read yet. We are adding them progressively.

Companies sharing a theme

Documents

See all timely disclosures See all statutory filings

News

See all news

Key numbersShowing 8 of 20

PER

1,931.12How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.

PBR

1.17How many times the company's net assets? Around 1x is generally considered a benchmark.

ROE

0.1%Earning power. A figure above 10% is generally considered good.

Dividend yield

0.0%The annual dividend as a percentage of the share price.

Market capitalization

¥3.9bnShare price × number of shares. The value of the entire company.

Equity ratio

43.8%The proportion of assets funded by money that does not have to be repaid.

Operating margin

3.0%The percentage of revenue remaining from the company’s core business.

Revenue growth (3 years)

-63.9%The average annual growth in sales over the past three years.

What to watch next

Specific projects arising from the business alliance with ソニーNC for AI-enabled RevOps support, including joint proposals and contract wins

From July 2026 onward, depending on the timing of project development following the allianceImpact MediumLikelihood Medium

Progress in integrating Sales Lab, acquired in October 2025, including cross-selling, gross margins, and project value, and the impact on results from the 43rd fiscal year onward

Upcoming quarterly earnings results, in the second half of 2026Impact HighLikelihood Medium

The contribution of 亞星通, acquired in January 2026, to consolidated results, including growth in overseas revenue and profitability

Second half of 2026 to first half of 2027Impact HighLikelihood Medium

The impact on revenue and workload of strategic or operating-rule changes by advertising platforms such as Google, LINE Yahoo, and Meta

Irregularly, requiring continuous monitoringImpact MediumLikelihood High

The adequacy of the company’s operations concerning advertising regulations, misleading representations, personal information, and information security, including the PrivacyMark, and whether any serious incidents occur

Ongoing, becoming apparent if an incident occursImpact HighLikelihood Low

What to watch next

Who owns itTop holders total 70.9%

Listed holders 70.9%Everyone else 29.1%

Koyanaka Shigeki (小谷中茂樹)19.97%

Mizuno Masahiro (水野昌広)15.85%

メディックス Employee Stock Ownership Association9.37%

Koyanaka Kazuki (小谷中一樹)6.65%

Tanaka Masanori (田中正則)5.61%

株式会社フォローワンズハート5.48%

株式会社EPARK3.90%

Rakuten Securities, Inc. (shared account)1.69%

2 other listed holders2.41%

Who owns it
Holder	Ownership (%)
Koyanaka Shigeki (小谷中茂樹)	19.97
Mizuno Masahiro (水野昌広)	15.85
メディックス Employee Stock Ownership Association	9.37
Koyanaka Kazuki (小谷中一樹)	6.65
Tanaka Masanori (田中正則)	5.61
株式会社フォローワンズハート	5.48
株式会社EPARK	3.90
Rakuten Securities, Inc. (shared account)	1.69
2 other listed holders	2.41

This company's documents

Filings

Timely disclosures